Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.95%
SPX
-0.77%
IXIC
-0.87%
FTSE
+0.01%
N225
+0.09%
AXJO
+0.41%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Key Stats

Market Cap
1.01B
Dividend Yield
0.00%
P/E Ratio
-12.98
EPS
-0.62
Revenue
660.57M
Avg. Volume
7.05M

Recently from Cashu

publisher logo
Cashu

Neogenomics Partners with AEON to Boost $NEO in Everyday Crypto Payments

10 days ago
publisher logo
Cashu

NeoGenomics to Release 2024 Financial Results and Strategic Insights on February 18, 2025

3 months ago
publisher logo
Cashu

NeoGenomics Prepares for Q4 2024 Financial Results Announcement and Insights Session

3 months ago

About

What does NEO do?
NeoGenomics, a clinical laboratory company based in Fort Myers, Florida, specializes in cancer genetics diagnostic testing and pharma services, employing 2,100 staff since its IPO in December 2012. Its services include clinical cancer testing and advanced diagnostics for healthcare providers and pharmaceutical companies.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Florida, USA
Website
http://www.neogenomics.com
Stocks
Health Care
neo
Neogenomics
NEO
-0.15 (-1.91%)
7.69
USD
At close at May 06, 20:37 UTC
Summary
News
Signals
Benchmarks
Financials